Alejandro Lopez-Soto
Overview
Explore the profile of Alejandro Lopez-Soto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Plaza-Florido A, Galvez B, Lopez J, Santos-Lozano A, Zazo S, Rincon-Castanedo C, et al.
Physiol Genomics
. 2024 Sep;
56(12):833-844.
PMID: 39311839
The impact of exercise on pediatric tumor biology is essentially unknown. We explored the effects of regular exercise on tumor proteome profile (as assessed with liquid chromatography with tandem mass...
2.
Fiuza-Luces C, Valenzuela P, Galvez B, Ramirez M, Lopez-Soto A, Simpson R, et al.
Nat Rev Immunol
. 2024 Feb;
24(3):229.
PMID: 38302654
No abstract available.
3.
Fiuza-Luces C, Valenzuela P, Galvez B, Ramirez M, Lopez-Soto A, Simpson R, et al.
Nat Rev Immunol
. 2023 Oct;
24(4):282-293.
PMID: 37794239
Regular physical activity is associated with lower cancer incidence and mortality, as well as with a lower rate of tumour recurrence. The epidemiological evidence is supported by preclinical studies in...
4.
Quintana-Torres D, Valle-Cao A, Bousquets-Munoz P, Freitas-Rodriguez S, Rodriguez F, Lucia A, et al.
Aging Cell
. 2023 Aug;
22(10):e13952.
PMID: 37565451
Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disease caused by nuclear envelope alterations that lead to accelerated aging and premature death. Several studies have linked health and longevity to...
5.
Sordo-Bahamonde C, Lorenzo-Herrero S, Martinez-Perez A, Gonzalez-Rodriguez A, Payer A, Gonzalez-Garcia E, et al.
Cancer Immunol Immunother
. 2023 Apr;
72(7):2529-2539.
PMID: 37041226
Patients with chronic lymphocytic leukemia (CLL) progressively develop marked immunosuppression, dampening innate and adaptive-driven antitumor responses. However, the underlying mechanisms promoting immune exhaustion are largely unknown. Herein, we provide new...
6.
Ugalde A, Bretones G, Rodriguez D, Quesada V, Llorente F, Fernandez-Delgado R, et al.
EMBO J
. 2022 Sep;
41(21):e110727.
PMID: 36124427
Better understanding on interactions between SARS-CoV-2 and host cells should help to identify host factors that may be targetable to combat infection and COVID-19 pathology. To this end, we have...
7.
Sordo-Bahamonde C, Lorenzo-Herrero S, Gonzalez-Rodriguez A, Payer A, Gonzalez-Garcia E, Lopez-Soto A, et al.
Cancers (Basel)
. 2021 Apr;
13(9).
PMID: 33925565
The inclusion of monoclonal antibodies targeting immune checkpoints such PD-1/PD-L1 or CTLA-4 has revolutionized the landscape of anti-cancer therapy. However, PD-1 and CTLA-4 blockade failed to achieve clinical benefit in...
8.
Sordo-Bahamonde C, Lorenzo-Herrero S, Gonzalez-Rodriguez A, Payer A, Gonzalez-Garcia E, Lopez-Soto A, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33917094
Chronic lymphocytic leukemia (CLL) is characterized by progressive immunosuppression and diminished cancer immunosurveillance. Immune checkpoint blockade (ICB)-based therapies, a major breakthrough against cancer, have emerged as a powerful tool to...
9.
Sordo-Bahamonde C, Lorenzo-Herrero S, Payer A, Gonzalez S, Lopez-Soto A
Int J Mol Sci
. 2020 May;
21(10).
PMID: 32466293
Natural killer (NK) cells are major contributors to immunosurveillance and control of tumor development by inducing apoptosis of malignant cells. Among the main mechanisms involved in NK cell-mediated cytotoxicity, the...
10.
Dolcetti R, Lopez-Soto A, Dal Col J
Front Immunol
. 2020 Apr;
11:507.
PMID: 32296426
No abstract available.